Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $555 | $274 | $319 | $114 |
| - Cash | $50 | $42 | $58 | $47 |
| + Debt | $866 | $865 | $29 | $37 |
| Enterprise Value | $1,370 | $1,097 | $291 | $104 |
| Revenue | $142 | $113 | $127 | $121 |
| % Growth | 25.7% | -11% | 5.2% | – |
| Gross Profit | $39 | $15 | $37 | $20 |
| % Margin | 27.7% | 13.7% | 29.1% | 17% |
| EBITDA | $39 | -$15 | $49 | $9 |
| % Margin | 27.3% | -13.3% | 38.9% | 7.4% |
| Net Income | -$196 | -$41 | -$9 | -$12 |
| % Margin | -137.9% | -36.4% | -7.3% | -9.7% |
| EPS Diluted | -0.512 | -0.11 | -0.025 | -0.031 |
| % Growth | -365.5% | -347.2% | 20.9% | – |
| Operating Cash Flow | $22 | $5 | $18 | $20 |
| Capital Expenditures | -$12 | -$3 | -$1 | -$2 |
| Free Cash Flow | $10 | $3 | $17 | $18 |